|
Median age, years (range)
|
34.0 (18–79)
|
33.5 (19–55)
|
|
Female, n (%)
|
16 (31%)
|
16 (32%)
|
|
Race/ethnicity, n (%)
| | |
|
African American, non-Hispanic
|
29 (57%)
|
33 (66%)
|
|
Hispanic, non-African American
|
18 (35%)
|
13 (26%)
|
|
African American and Hispanic
|
3 (6%)
|
4 (8%)
|
|
Asian
|
1 (2%)
|
0
|
|
Median plasma HIV-1 RNA, log10 copies/mL
|
4.96
|
4.82
|
|
≥100,000 copies/mL, n (%)
|
22 (43%)
|
20 (40%)
|
|
Median CD4 cell count, cells/mm3 (range)
|
237.0 (19–1061)
|
272.5 (19–699)
|
|
<200 cells/mm3, n (%)
|
21 (41%)
|
17 (34%)
|
|
<50 cells/mm3, n (%)
|
3 (6%)
|
7 (14%)
|
|
Positive hepatitis C serology
|
5 (10%)
|
5 (10%)
|
|
CDC classification for HIV infection, n (%)
| | |
|
Category A
|
40 (78%)
|
43 (86%)
|
|
Category B
|
4 (8%)
|
7 (14%)
|
|
Category C
|
7 (14%)
|
0
|
|
Framingham risk score <5%*, n (%)
|
28 (78%)
|
28 (88%)
|
|
Diabetes type II, n (%)
|
3 (6%)
|
1 (2%)
|
|
Hypercholesterolemia, n (%)
|
17 (33%)
|
14 (28%)
|
|
Hypertension, n (%)
|
9 (18%)
|
12 (24%)
|
|
Tobacco use
| | |
|
Never smoked, n (%)
|
26 (51%)
|
19 (38%)
|
|
Current smoker, n (%)
|
20 (39%)
|
20 (40%)
|
|
Former smoker, n (%)
|
5 (10%)
|
11 (22%)
|
|
Years smoked, median (range)†
|
10 (2–39)
|
10 (0–33)
|
